Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125386891 | 12538689 | 1 | I | 20130129 | 20160708 | 20160708 | EXP | US-CIPLA LTD.-2013US00383 | CIPLA | SPIGEL DR, GRECO FA, WATERHOUSE DM, SHIPLEY DL, ZUBKUS JD, BURY MJ, ET AL.,. PHASE II TRIAL OF IXABEPILONE AND CARBOPLATIN WITH OR WITHOUT BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SMALL-CELL LUNG CANCER. LUNG CANCER. 2012;78:70 TO 75 | 0.00 | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125386891 | 12538689 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | AUC 6, ON DAY 1 OF EACH 21 DAY CYCLE | 0 | ||||||||||
| 125386891 | 12538689 | 2 | SS | Ixabepilone | IXABEPILONE | 1 | Intravenous (not otherwise specified) | 30 MG/M2, OVER 3 HOURS ON DAY 1 OF EACH 21 DAY CYCLE | 0 | 30 | MG/M**2 | ||||||||
| 125386891 | 12538689 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125386891 | 12538689 | 1 | Non-small cell lung cancer |
| 125386891 | 12538689 | 2 | Non-small cell lung cancer |
| 125386891 | 12538689 | 3 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125386891 | 12538689 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125386891 | 12538689 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |